FDA TRansparency Blog Header www.hhs.gov www.hhs.gov FDA U.S. Food and Drug Administration FDA Transparency Blog

« The Transparency Task Force’s Third Question | Main | The Transparency Task Force’s Fourth Question »

June 18, 2009

Would you like to have a statement read at the the Task Force public meeting?,

If you cannot attend the public meeting on transparency in person and would like to have a statement read at the June 24th Transparency Task Force public meeting, please email that statement to Transparency.Meeting@fda.hhs.gov. The statement will be read to the Task Force by a FDA staff member during the public meeting. The statement should be 5 minutes or less so we can accommodate all people who want to speak.

 

Note: Statements should be submitted by 5 p.m. Monday, June 22.

 

Thank you and we look forward to your input and participation.

FDA Transparency Task Force

 

 


Posted on June 18, 2009 at 02:28 PM |

|

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00e0097fa0008833011570340bd7970c

Listed below are links to weblogs that reference Would you like to have a statement read at the the Task Force public meeting?,:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

FDA Approved Contract Manufacturer

I would like to send something. When will be the deadline for this?

Posted by: FDA Approved Contract Manufacturer | June 19, 2009 at 01:07 AM

Ruth Walstra

I would like to see a data base that I could go to on the web,and searching by a drug name, be able to find out any adverse reactions, both during the drugs trials and after it is approved. I wqould also like to see a requirement that for any Doctor treating a disease, a report would have to be made as to what drugs the person was taking at the time of the diagnoses. That way we would see trends developing instead of waiting until enough people die and finally the drug companies are sued, before a drug carries a black warning box or is taken off the market.

Posted by: Ruth Walstra | June 20, 2009 at 10:31 PM

Travian

Important, but 5 minutes is not enough transparency about.
Nice post.

Posted by: Travian | July 25, 2009 at 12:24 AM

marre sadig

Why are all the comments from the Transparency FDA people?
I just tried to get info on Zyprexa and couldn't find anything
relevant, hard to find a way to do more than look at the very limited offering.
No mention of dangers or warnings about not giving it to the elderly.
I might have missed the link to that info, but still it shouldn't take Sherlock Holmes to find it on the webpage.

Why all the labeling revisions?
Is there something wrong with what it says?

Posted by: marre sadig | August 06, 2009 at 12:31 AM

evden eve nakliyat

No mention of dangers or warnings about not giving it to the elderly.
I might have missed the link to that info, but still it shouldn't take Sherlock Holmes to find it on the webpage.

Posted by: evden eve nakliyat | September 28, 2009 at 11:08 AM

Verify your Comment

Previewing your Comment

Posted by:  | 

This is only a preview. Your comment has not yet been posted.

Working...
Your comment could not be posted. Error type:
Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.

Working...

Post a comment

Comments are moderated, and will not appear until the author has approved them.

I would like to send something. When will be the deadline for this?

Posted by: FDA Approved Contract Manufacturer | June 19, 2009 at 01:07 AM

I would like to see a data base that I could go to on the web,and searching by a drug name, be able to find out any adverse reactions, both during the drugs trials and after it is approved. I wqould also like to see a requirement that for any Doctor treating a disease, a report would have to be made as to what drugs the person was taking at the time of the diagnoses. That way we would see trends developing instead of waiting until enough people die and finally the drug companies are sued, before a drug carries a black warning box or is taken off the market.

Posted by: Ruth Walstra | June 20, 2009 at 10:31 PM

Important, but 5 minutes is not enough transparency about.
Nice post.

Posted by: Travian | July 25, 2009 at 12:24 AM

Why are all the comments from the Transparency FDA people?
I just tried to get info on Zyprexa and couldn't find anything
relevant, hard to find a way to do more than look at the very limited offering.
No mention of dangers or warnings about not giving it to the elderly.
I might have missed the link to that info, but still it shouldn't take Sherlock Holmes to find it on the webpage.

Why all the labeling revisions?
Is there something wrong with what it says?

Posted by: marre sadig | August 06, 2009 at 12:31 AM

No mention of dangers or warnings about not giving it to the elderly.
I might have missed the link to that info, but still it shouldn't take Sherlock Holmes to find it on the webpage.

Posted by: evden eve nakliyat | September 28, 2009 at 11:08 AM